HER2 testing in breast cancer: NCCN Task Force report and recommendations.
Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM, _ _. HER2 testing in breast cancer: NCCN Task Force report and recommendations. Journal Of The National Comprehensive Cancer Network 2006, 4 Suppl 3: s1-22; quiz s23-4. PMID: 16813731, DOI: 10.6004/jnccn.2006.2003.Peer-Reviewed Original ResearchConceptsBreast cancerHER2 testingHER2 statusIHC scoreMetastatic settingCopies/cellPredictive factorsHER2 expressionTask force membersEvidence-based consensus approachInvasive breast cancerCancer patient evaluationTask ForceBreast cancer panelGene amplificationBreast cancer tumorsAreas of controversyAdjuvant settingHER2 biologyMedical oncologyPatient evaluationClinical trialsMultidisciplinary panelSurgical oncologyHER2